4//SEC Filing
Agresta Samuel 4
Accession 0001140361-22-023318
CIK 0001113148other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 8:42 PM ET
Size
12.3 KB
Accession
0001140361-22-023318
Insider Transaction Report
Form 4
Agresta Samuel
Chief Medical Officer
Transactions
- Award
Stock Option(right to buy)
2022-06-16+45,000→ 45,000 totalExercise: $0.68Exp: 2032-06-16→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer.
Documents
Issuer
INFINITY PHARMACEUTICALS, INC.
CIK 0001113148
Entity typeother
Related Parties
1- filerCIK 0001748961
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 8:42 PM ET
- Size
- 12.3 KB